EXTH-65. USING METHYLATION PROFILES TO GUIDE THE REPURPOSING OF CHEMOTHERAPIES AGAINST HIGH-RISK MENINGIOMAS

Meningioma is the most common primary brain tumor with nearly thirty thousand new cases in the US every year. While most meningiomas grow slowly, hence categorized as benign, they can still impact brain structures and result in disability or lethality. Currently, there is no widely accepted chemothe...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Neuro Oncol
Auteurs principaux: Tran, Anh, Scholtens, Denise, Zhang, Lyndsee, Pokorny, Jenny, Baran, Aneta, Sahm, Felix, Aldape, Kenneth, James, Charles, Horbinski, Craig
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2020
Sujets:
Preclinical Experimental Therapeutics
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC7651328/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noaa215.419
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires